You are here:  Home » Disorders A - Z » Refsum Disease » 

NINDS Refsum Disease Information Page

Skip secondary menu
Synonym(s):   Phytanic Acid Storage Disease, Heredopathia Atactica Polyneuritiformis

Table of Contents (click to jump to sections)


What is Refsum Disease?

Adult Refsum disease (ARD) is one of a group of genetic diseases called leukodystrophies, which damage the white matter of the brain and affect motor movements.  Due to a genetic abnormality, people with ARD disease lack the enzyme that breaks down phytanic acid, a substance commonly found in foods. As a result, toxic levels of phytanic acid build up in the brain, blood, and other tissues.  The disease usually begins in late childhood with increasing night blindness due to degeneration of the retina (retinitis pigmentosa) and loss of the sense of smell (anosmia).   If the disease progresses, other symptoms may include deafness, problems with balance and coordination (ataxia), weakness or numbness (peripheral neuropathy), dry and scaly skin (ichthyosis), and heartbeat abnormalities (cardiac arrhythmias).  Some individuals will have shortened bones in their fingers or toes, or a visibly shortened fourth toe.  Although the disease usually appears in early childhood, some people will not develop symptoms until their 40s or 50s.

Is there any treatment?

The primary treatment for  ARD is to restrict or avoid foods that contain phytanic acid, including dairy products; beef and lamb; and fatty fish such as tuna, cod, and haddock.  Some individuals may also require plasma exchange (plasmapheresis) in which blood is drawn, filtered, and reinfused back into the body, to control the buildup of phytanic acid.

What is the prognosis?

ARD is the most treatable of the leukodystrophies because phytanic acid is not produced by the body, but is only found in foods.  With treatment, muscle weakness, numbness, and dry and scaly skin generally disappear.  However, vision and hearing problems may persist and the sense of smell may not return.  Untreated, ARD can lead to death caused by heartbeat abnormalities. 

What research is being done?

The National Institute of Neurological Disorders and Stroke (NINDS) conducts research related to ARD in its laboratories at the National Institutes of Health (NIH), and also supports additional research through grants to major medical institutions across the country.  Research is focused on finding better ways to prevent, treat, and ultimately cure disorders such as the leukodystrophies.  

NIH Patient Recruitment for Refsum Disease Clinical Trials

Organizations

United Leukodystrophy Foundation
2304 Highland Drive
Sycamore, IL   60178
office@ulf.org
http://www.ulf.org
Tel: 815-895-3211 800-728-5483
Fax: 815-895-2432

  


Prepared by:
Office of Communications and Public Liaison
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, MD 20892



NINDS health-related material is provided for information purposes only and does not necessarily represent endorsement by or an official position of the National Institute of Neurological Disorders and Stroke or any other Federal agency. Advice on the treatment or care of an individual patient should be obtained through consultation with a physician who has examined that patient or is familiar with that patient's medical history.

All NINDS-prepared information is in the public domain and may be freely copied. Credit to the NINDS or the NIH is appreciated.

Last updated February 14, 2007